
### [MONDO:0018944](http://purl.obolibrary.org/obo/MONDO_0018944)
**Label:** gestational trophoblastic neoplasm

**Subclasses:** [MONDO:0004489](http://purl.obolibrary.org/obo/MONDO_0004489) (fallopian tube gestational choriocarcinoma), [MONDO:0020549](http://purl.obolibrary.org/obo/MONDO_0020549) (invasive hydatidiform mole), [MONDO:0009273](http://purl.obolibrary.org/obo/MONDO_0009273) (hydatidiform mole, recurrent, 1), [MONDO:0016787](http://purl.obolibrary.org/obo/MONDO_0016787) (epithelioid trophoblastic tumor), [MONDO:0013671](http://purl.obolibrary.org/obo/MONDO_0013671) (hydatidiform mole, recurrent, 2), [MONDO:0020550](http://purl.obolibrary.org/obo/MONDO_0020550) (gestational choriocarcinoma), [MONDO:0006374](http://purl.obolibrary.org/obo/MONDO_0006374) (placental choriocarcinoma), [MONDO:0004294](http://purl.obolibrary.org/obo/MONDO_0004294) (gestational ovarian choriocarcinoma), [MONDO:0020552](http://purl.obolibrary.org/obo/MONDO_0020552) (placental site trophoblastic tumor), [MONDO:0004490](http://purl.obolibrary.org/obo/MONDO_0004490) (gestational uterine corpus choriocarcinoma), 

**Mapped go classes:** [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding), 

**Class expressions from DL-Learner:**

- [GO:0032090](http://purl.obolibrary.org/obo/GO_0032090) (Pyrin domain binding) 60.00%
- [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity) 60.00%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 60.00%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 60.00%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 60.00%


